Microdosing & Medications: A Pharmacist’s Guide to Safety

We sat down with Ben Malcolm, PharmD, MPH, psychopharmacology consultant and founder of Spirit Pharmacist, to unpack what is currently known about microdosing when psychiatric medications are in the mix. The conversation covered common interaction patterns, who may need to pause or proceed with caution, and what the research and pharmacology do and do not support.

Inside This Conversation

Microdosing and Medications
Ben walked through how SSRIs, SNRIs, stimulants, mood stabilizers, and other classes can blunt, amplify, or make responses unpredictable.

Contraindications and Caution Zones
We discussed conditions, recent dose changes, and combinations where slowing down or holding off makes sense.

What the Evidence Shows
A read on the data from clinical trials, pharmacology, and real‑world reports, along with the gaps that remain in areas like women's health.


Note: This session was for information only and did not provide medical advice. For personal decisions, please consult a healthcare professional.

Speakers & Hosts

Ben Malcolm

PharmD, MPH, Psychopharmacology Consultant and Founder of Spirit Pharmacist

Paul F. Austin

Stephanie Karzon Abrams

Founder of Beyond Consulting
Research Director at Microdosing Collective
MSc Clinical Neuropharmacologist

NEWSLETTER

Subscribe to THE DOSE and get the latest microdosing news, expert insights, legalization updates, and exclusive events—delivered straight to your inbox! 📩

Thank you! Check your email for confirmation.